Transcatheter aortic valve replacement: Current developments, ongoing issues, future outlook

Cardiology in Review

Volumn 21, Issue 2, 2013, Pages 55-76

  Tang, Gilbert H L ^a   Lansman, Steven L ^a   Cohen, Martin ^a   Spielvogel, David ^a   Cuomo, Linda ^a   Ahmad, Hasan ^a   Dutta, Tanya ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

transcatheter aortic valve implantation; transcatheter aortic valve replacement; valve in valve

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; BALLOON DILATATION; BICUSPID AORTIC VALVE; CARDIOEMBOLIC STROKE; CARDIOVASCULAR EQUIPMENT; CARPENTIER EDWARDS BIOPROSTHESIS; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLETE HEART BLOCK; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEVICE SAFETY; DISEASE SEVERITY; EDWARDS SAPIEN VALVE; EMBOLIC PROTECTION FILTER; EUROPE; EUROSCORE; FRAIL ELDERLY; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; IMPLANTED HEART PACEMAKER; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MEDICAID; MEDICAL SOCIETY; MEDICARE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MULTICENTER STUDY (TOPIC); MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROSTHESIS FAILURE; PROSTHESIS PATIENT MISMATCH; PROSTHETIC VALVE DYSFUNCTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REIMBURSEMENT; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; STERNOTOMY; STS RISK SCORE; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THORACOTOMY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR DISEASE;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; RISK ASSESSMENT;

EID: 84873743201     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318283bb3d     Document Type: Review

References (208)

1. Bande M, Michev I, Sharp AS, et al. Percutaneous transcatheter aortic valve implantation: past accomplishments, present achievements and applications, future perspectives. Cardiol Rev. 2010;18:111-124.
2. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcifc aortic stenosis: frst human case description. Circulation. 2002;106:3006-3008. (Pubitemid 35440280)
3. Généreux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J. 2012;33:2388-2398.
4. Généreux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J. 2012;33:2399-2402.
5. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;60:483-492.
6. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Car-diol. 2012;59:1200-1254.
7. Miller DC. When is an aortic stenosis patient "too sick to treat"? The PARTNER Cohort C patient. Transcatheter Cardiovascular Therapeutics (TCT) 25th Annual Symposium. San Francisco, CA; 2011.
8. Lim S. A primer on risk scores: use and abuse. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
9. Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 2012;5:974-981.
10. Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:489-496.
11. Green P. Defning and measuring frailty in aortic stenosis patients: insights from the Columbia TAVR experience. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
12. Tommaso CL, Bolman RM 3rd, Feldman T, et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcath-eter aortic valve replacement. J Am Coll Cardiol. 2012;59:2028-2042.
13. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint defnitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253-269.
14. Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after trans-catheter aortic valve replacement using valve academic research consortium defnitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317-2326.
15. Kappetein A P, Head SJ, Généreux P, et al. Updated standardized endpoint defnitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-1454.
16. Ya n TD, Cao C, Martens-Nielsen J, et al. Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: A systematic review. J Thorac Cardiovasc Surg. 2010;139:1519-1528.
17. Jilaihawi H, Chakravarty T, Weiss RE, et al. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Car-diovasc Interv. 2012;80:128-138.
18. Leon MB, Smith CR, Mack M, et al.; PARTNER Trial Investigators. Trans-catheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
19. Smith CR, Leon MB, Mack MJ, et al.; PARTNER Trial Investigators. Trans-catheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
20. Makkar RR, Fontana G P, Jilaihawi H, et al.; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704.
21. Kodali SK, Williams MR, Smith CR, et al.; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
22. Kapadia SK. Three-year outcomes of transcatheter aortic valve replacement (TAVR) in "inoperable" patients with severe aortic stenosis: the PARTNER trial. Transcatheter Cardiovascular Therapeutics (TCT) symposium. Miami, FL; 2012.
23. Kodali SK. New data from PARTNER continued access (non-randomized): transfemoral outcomes after TAVR. Transcatheter Cardiovascular Therapeutics (TCT) symposium. Miami, FL; 2012.
24. Dewey TM. New data from PARTNER continued access (non-randomized): transapical outcomes after TAVR. Transcatheter Cardiovascular Therapeutics (TCT) symposium. Miami, FL; 2012.
25. Wendler O. The multicenter SOURCE XT TAVR registry. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
26. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69.
27. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425-433.
28. TM transcatheter heart valve in patients with large aortic annulus. Eur J Cardiothorac Surg. 2012 Apr 20 (Epub ahead of print).
29. Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383-389.
30. Serruys P W. Update from the randomized SURTAVI trial. Transcatheter Cardiovascular Therapeutics (TCT) symposium. Miami, FL; 2012.
31. Linke A. Medtronic CoreValve ADVANCE Study. Transcatheter Cardiovascular Therapeutics (TCT) symposium. Miami, FL; 2012.
32. Wong DR, Ye J, Cheung A, et al. Technical considerations to avoid pitfalls during transapical aortic valve implantation. J Thorac Cardiovasc Surg. 2010;140:196-202.
33. Walther T, Thielmann M, Kempfert J, et al. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II). Eur J Cardiothorac Surg. 2012;42:278-283.
34. Ye J, Cheung A, Lichtenstein S V, et al. Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. J Thorac Cardiovasc Surg. 2009;137:167-173.
35. Ye J, Webb JG, Cheung A, et al. Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years. J Thorac Cardiovasc Surg. 2012 Jun 12 (Epub ahead of print).
36. Ye J, Cheung A, Lichtenstein S V, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg. 2010;139:1107-13, 1113.e1.
37. Unbehaun A, Pasic M, Drews T, et al. Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic valve implantation. Ann Thorac Surg. 2011;92:1315-1323.
38. Walther T, Kempfert J, Rastan A, et al. Transapical aortic valve implantation at 3 years. J Thorac Cardiovasc Surg. 2012;143:326-331.
39. Wendler O, Walther T, Schroefel H, et al, on behalf of the SOURCE investigators. Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. Eur J Cardiothorac Surg. 2012 May 30 (Epub ahead of print).
40. Litzler P Y, Borz B, Smail H, et al. Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesis. Arch Cardiovasc Dis. 2012;105:141-145.
41. D'Onofrio A, Fusari M, Abbiate N, et al. Transapical aortic valve implantation in high-risk patients with severe aortic valve stenosis. Ann Thorac Surg. 2011;92:1671-1677.
42. Mack MJ. Transapical is making a comeback. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
43. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or trans-apical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303-311.
44. Bleiziffer S, Ruge H, Mazzitelli D, et al. Survival after transapical and trans-femoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg. 2009;138:1073-1080.
45. Laborde JC. The subclavian axillary approach: advantages, disadvantages, technique, and outcomes. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
46. Petronio A, Giannini C, De Carlo M, et al. Antegrade percutaneous valve implantation for mitral ring dysfunction, a challenging case. Catheter Cardio-vasc Interv. 2012;80:700-703.
47. Caceres M, Braud R, Roselli EE. The axillary/subclavian artery access route for transcatheter aortic valve replacement: a systematic review of the literature. Ann Thorac Surg. 2012;93:1013-1018.
48. Bapat VN, Attia RQ, Thomas M. Distribution of calcium in the ascending aorta in patients undergoing transcatheter aortic valve implantation and its relevance to the transaortic approach. JACC Cardiovasc Interv. 2012;5:470-476.
49. Etienne P Y, Papadatos S, El Khoury E, et al. Transaortic transcatheter aortic valve implantation with the Edwards SAPIEN valve: feasibility, technical considerations, and clinical advantages. Ann Thorac Surg. 2011;92:746-748.
50. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv. 2010;75:1129-1136.
51. Gerosa G, Fabozzo A, Bianco R, et al. Transaortic balloon-expandable aortic valve implantation. J Thorac Cardiovasc Surg. 2012;143:1453-1455.
52. Bapat V, Khawaja MZ, Attia R, et al. Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach. Catheter Cardio-vasc Interv. 2012;79:733-740.
53. Soppa G, Roy D, Brecker S, et al. Early experience with the transaortic approach for transcatheter aortic valve implantation. J Thorac Cardiovasc Surg. 2012;143:1225-1227.
54. Bruschi G, de Marco F, Botta L, et al. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation. Ann Thorac Surg. 2012;94:497-503.
55. Bapat V. The transaortic approach: advantages, disadvantages, technique, outcomes. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
56. Laborde JC. Valve-in-valve for bioprosthetic valve failure: CoreValve experience. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
57. Guyton R, Block P, Thourani V, et al. Carotid artery access for transcatheter aortic valve replacement (TAVR). Catheter Cardiovasc Interv. 2012 Aug 6 (Epub ahead of print).
58. Modine T, Lemesle G, Azzaoui R, et al. Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: frst case report. J Thorac Cardiovasc Surg. 2010;140:928-929.
59. Modine T, Sudre A, Delhaye C, et al. Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes. Ann Thorac Surg. 2012;93:1489-1494.
60. Bruschi G, De Marco F, Oreglia J, et al. Percutaneous implantation of Cor-Valve aortic prostheses in patients with a mechanical mitral valve. Ann Thorac Surg. 2009;88:e50-e52.
61. Soon JL, Ye J, Lichtenstein S V, et al. Transapical transcatheter aortic valve implantation in the presence of a mitral prosthesis. J Am Coll Cardiol. 2011;58:715-721.
62. Attia R, Bapat V. Transcatheter aortic valve implantation for treatment of failing homograft with pre-existing mechanical mitral prosthesis. Catheter Car-diovasc Interv. 2011 Nov 25 (Epub ahead of print).
63. Bruschi G, De Marco F, Oreglia J, et al. Transcatheter self-expandable aortic valve implantation after undersized mitral annuloplasty. Ann Thorac Surg. 2011;92:1881-1883.
64. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848-1857.
65. Gurvitch R, Cheung A, Ye J, et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol. 2011;58:2196-2209.
66. Toggweiler S, Wood DA, Rodés-Cabau J, et al. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv. 2012;5:571-577.
67. Giri J, Bortnick AE, Wallen T, et al. Procedural and clinical outcomes of the valve-in-valve technique for severe aortic insuffciency after balloon-expandable trans-catheter aortic valve replacement. Catheter Cardiovasc Interv. 2012;80:139-147.
68. Taramasso M, Sharp AS, Maisano F. First-in-man case report of the use of an Edwards-Sapien valve to treat a regurgitant CoreValve aortic valve prosthesis. Catheter Cardiovasc Interv. 2010;75:51-55.
69. van der Lienden BT, Swinkels BM, Heijmen RH, et al. First valve-in-valve direct transaortic CoreValve implantation in an insuffcient Sapien valve. JACC Cardiovasc Interv. 2011;4:1049-1050.
70. Hoffmann R, Mollmann H, Lotf S. Transcatheter aortic valve-in-valve implantation of a corevalve in a degenerated stenotic sapien heart valve prosthesis. Catheter Cardiovasc Interv. 2012 Jun 18 (Epub ahead of print).
71. Eggebrecht H, Schäfer U, Treede H, et al. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardio-vasc Interv. 2011;4:1218-1227.
72. Wilbring M, Sill B, Tugtekin SM, et al. Transcatheter valve-in-valve implantation for deteriorated aortic bioprosthesis: initial clinical results and follow-up in a series of high-risk patients. Ann Thorac Surg. 2012;93:734-741.
73. Bruschi G, DeMarco F, Oreglia J, et al. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated aortic bioprosthesis. J Cardio-vasc Med (Hagerstown). 2010;11:182-185.
74. Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses Core-Valve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol. 2010;55:97-101.
75. Gotzmann M, Mügge A, Bojara W. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses-valve-in-valve technique. Catheter Cardiovasc Interv. 2010;76:1000-1006.
76. Bedogni F, Laudisa ML, Pizzocri S, et al. Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprosthe-ses. JACC Cardiovasc Interv. 2011;4:1228-1234.
77. Seiffert M, Conradi L, Baldus S, et al. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated biopros-theses. J Thorac Cardiovasc Surg. 2012;143:617-624.
78. Dvir D. Transcatheter aortic-valve implantation for the treatment of degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
79. Webb JG. Valve in valve: Edwards balloon-expandable valve. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
80. Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-invalve registry. Circulation. 2012;126:2335-2344.
81. Klotz S, Scharfschwerdt M, Richardt D, et al. Failed valve-in-valve transcath-eter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:591-592.
82. Caudron J, Eltchaninoff H, Godin M, et al. Cardiac multislice computed tomography after transcatheter aortic valve implantation: features after "valve-in-valve" implantation for degenerative stented aortic bioprosthesis. Arch Car-diovasc Dis. 2012;105:190-192.
83. Bapat V, Attia R, Redwood S, et al. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic biopros-thesis: Technical considerations and results. J Thorac Cardiovasc Surg. 2012;144:1372-1380.
84. Cheung AW, Gurvitch R, Ye J, et al. Transcatheter transapical mitral valve-invalve implantations for a failed bioprosthesis: a case series. J Thorac Cardio-vasc Surg. 2011;141:711-715.
85. de Weger A, Tavilla G, Ng AC, et al. Successful transapical transcatheter valve implantation within a dysfunctional mitral bioprosthesis. JACC Cardiovasc Imaging. 2010;3:222-223.
86. Cerillo AG, Chiaramonti F, Murzi M, et al. Transcatheter valve in valve implantation for failed mitral and tricuspid bioprosthesis. Catheter Cardio-vasc Interv. 2011;78:987-995.
87. Seiffert M, Conradi L, Baldus S, et al. Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc Interv. 2012;5:341-349.
88. Bruschi G, Barosi A, Colombo P, et al. Direct transatrial transcatheter SAPIEN valve implantation through right minithoracotomy in a degenerated mitral bio-prosthetic valve. Ann Thorac Surg. 2012;93:1708-1710.
89. Seiffert M, Baldus S, Conradi L, et al. Simultaneous transcatheter aortic and mitral valve-in-valve implantation in a patient with degenerated bioprostheses and high surgical risk. Thorac Cardiovasc Surg. 2011;59:490-492.
90. Al Kindi AH, Salhab KF, Kapadia S, et al. Simultaneous transapical transcath-eter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis. J Thorac Cardiovasc Surg. 2012;144:e90-e91.
91. Hon JK, Cheung A, Ye J, et al. Transatrial transcatheter tricuspid valve-invalve implantation of balloon expandable bioprosthesis. Ann Thorac Surg. 2010;90:1696-1697.
92. Kempfert J, Blumenstein J, Chu M W, et al. Minimally invasive off-pump valve-in-a-ring implantation: the atrial transcatheter approach for re-operative mitral valve replacement after failed repair. Eur J Cardiothorac Surg. 2009;35:965-969.
93. Himbert D, Brochet E, Radu C, et al. Transseptal implantation of a transcath-eter heart valve in a mitral annuloplasty ring to treat mitral repair failure. Circ Cardiovasc Interv. 2011;4:396-398.
94. Bloomfeld GS, Gillam LD, Hahn RT, et al. A practical guide to multimo-dality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2012;5:441-455.
95. Tzikas A, Schultz CJ, Piazza N, et al. Assessment of the aortic annulus by multislice computed tomography, contrast aortography, and trans-thoracic echocardiography in patients referred for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2011;77:868-875.
96. Gurvitch R, Webb JG, Yuan R, et al. Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4:1235-1245.
97. Delgado V, Ng AC, van de Veire NR, et al. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur Heart J. 2010;31:1114-1123.
98. Delgado V, Kapadia S, Schalij MJ, et al. Transcatheter aortic valve implantation: implications of multimodality imaging in patient selection, procedural guidance, and outcomes. Heart. 2012;98:743-754.
99. Kempfert J, Van Linden A, Lehmkuhl L, et al. Aortic annulus sizing: echocar-diographic versus computed tomography derived measurements in comparison with direct surgical sizing. Eur J Cardiothorac Surg. 2012;42:627-633.
100. Willson AB, Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59:1287-1294.
101. Messika-Zeitoun D, Serfaty JM, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol. 2010;55:186-194.
102. Husser O, Rauch S, Endemann DH, et al. Impact of three-dimensional trans-esophageal echocardiography on prosthesis sizing for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2012;80:956-963.
103. Santos N, de Agustín JA, Almería C, et al. Prosthesis/annulus discongruence assessed by three-dimensional transoesophageal echocardiography: a predictor of signifcant paravalvular aortic regurgitation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2012;13:931-937.
104. Binder RK, Leipsic J, Wood D, et al. Prediction of optimal deployment projection for transcatheter aortic valve replacement: angiographic 3-dimen-sional reconstruction of the aortic root versus multidetector computed tomography. Circ Cardiovasc Interv. 2012;5:247-252.
105. Tzikas A, Schultz C, Van Mieghem NM, et al. Optimal projection estimation for transcatheter aortic valve implantation based on contrast-aortography: validation of a Prototype Software. Catheter Cardiovasc Interv. 2010;76:602-607.
106. Dvir D, Lavi I, Eltchaninoff H, et al. Multicenter evaluation of Edwards SAPIEN positioning during transcatheter aortic valve implantation with correlates for device movement during fnal deployment. JACC Cardiovasc Interv. 2012;5:563-570.
107. Tzamtzis S, Viquerat J, Yap J, et al. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys. 2013;35:125-130.
108. Nombela-Franco L, Webb JG, de Jaegere P P, et al: Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012; 126: 3041-53.
109. Miller DC, Blackstone EH, Mack MJ, et al.; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832-843.
110. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
111. Eltchaninoff H, Prat A, Gilard M, et al.; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197.
112. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after trans-catheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130-2138.
113. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
114. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
115. Zahn R, Gerckens U, Grube E, et al.; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: frst results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
116. Bosmans JM, Kefer J, De Bruyne B, et al.; Belgian TAVI Registry Participants. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12:762-767.
117. Rodes-Cabau J. Will embolic protection devices reduce strokes after TAVR. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Sci-entifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
118. Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after trans-catheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129-138.
119. Arnold M, Schulz-Heise S, Achenbach S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv. 2010;3:1126-1132.
120. Ghanem A, Müller A, Nähle C P, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427-1432.
121. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870-878.
122. Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28.
123. Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18-23.
124. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1637-1643.
125. Erdoes G, Basciani R, Huber C, et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur J Cardio-thorac Surg. 2012;41:778-783.
126. Szeto WY, Augoustides JG, Desai ND, et al. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg. 2011;26:348-354.
127. Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, et al. Predictive factors, effcacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5:499-512.
128. Kahlert P, Al-Rashid F, Döttger P, et al. Cerebral embolization during trans-catheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012;126:1245-1255.
129. Etienne P Y, Papadatos S, Pieters D, et al. Embol-X intraaortic flter and transaortic approach for improved cerebral protection in transcatheter aortic valve implantation. Ann Thorac Surg. 2011;92:e95-e96.
130. Onsea K, Agostoni P, Samim M, et al. First-in-man experience with a new embolic defection device in transcatheter aortic valve interventions. EuroIntervention. 2012;8:51-56.
131. Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8:43-50.
132. Gotzmann M, Korten M, Bojara W, et al. Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2012;110:1500-1506.
133. Abdel-Wahab M, Zahn R, Horack M, et al.; German transcatheter aortic valve interventions registry investigators. Aortic regurgitation after trans-catheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899-906.
134. Détaint D, Lepage L, Himbert D, et al. Determinants of signifcant paravalvu-lar regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv. 2009;2:821-827.
135. Colli A, D'Amico R, Kempfert J, et al. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp cal-cifcation on postoperative aortic regurgitation. J Thorac Cardiovasc Surg. 2011;142:1229-1235.
136. Samim M, Stella PR, Agostoni P, et al. A prospective " oversizing" strategy of the Edwards SAPIEN bioprosthesis: Results and impact on aortic regurgitation. J Thorac Cardiovasc Surg. 2012 Feb 27 [Epub].
137. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol. 2009;53:1883-1891.
138. Unbehaun A, Pasic M, Dreysse S, et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol. 2012;59:211-221.
139. Gilard M, Eltchaninoff H, Iung B, et al.; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-1715.
140. Sherif MA, Abdel-Wahab M, Stöcker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010;56:1623-1629.
141. Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defnes severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:1134-1141.
142. John D, Buellesfeld L, Yuecel S, et al. Correlation of Device landing zone calcifcation and acute procedural success in patients undergoing transcath-eter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv. 2010;3:233-243.
143. van der Boon RM, Nuis RJ, Van Mieghem NM, et al. New conduction abnormalities after TAVI-frequency and causes. Nat Rev Cardiol. 2012;9:454-463.
144. Meredith IT. Australia-New Zealand CoreValve transcatheter aortic valve study. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
145. Ussia G P, Barbanti M, Petronio AS, et al.; CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J. 2012;33:969-976.
146. Erkapic D, De Rosa S, Kelava A, et al. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23:391-397.
147. De Carlo M, Giannini C, Bedogni F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J. 2012;163:492-499.
148. Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Car-diol. 2012;60:1743-1752.
149. Houthuizen P, Van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720-728.
150. Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic fndings. JACC Cardiovasc Interv. 2012;5:540-551.
151. Muñoz-García AJ, Hernández-García JM, Jiménez-Navarro MF, et al. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. JACC Cardiovasc Interv. 2012;5:533-539.
152. Généreux P, Webb JG, Svensson LG, et al.; PARTNER Trial Investigators. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043-1052.
153. Gurvitch R, Tay EL, Wijesinghe N, et al. Transcatheter aortic valve implantation: lessons from the learning curve of the frst 270 high-risk patients. Catheter Cardiovasc Interv. 2011;78:977-984.
154. Genereux P, Kodali S, Leon MB, et al. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv. 2011;4:861-867.
155. Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110:1361-1367.
156. Stortecky S, Wenaweser P, Diehm N, et al. Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:515-524.
157. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113-118.
158. Maesen B, Nijs J, Maessen J, et al. Post-operative atrial fbrillation: a maze of mechanisms. Europace. 2012;14:159-174.
159. Rodes-Cabau J. Canadian TAVR Registry. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
160. Amat-Santos IJ, Rodés-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fbrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178-188.
161. Motloch LJ, Reda S, Rottlaender D, et al. Postprocedural atrial fbrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg. 2012;93:124-131.
162. Goel SS, Agarwal S, Tuzcu EM, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125:1005-1013.
163. Masson JB, Lee M, Boone RH, et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76:165-173.
164. Abdel-Wahab M, Mostafa AE, Geist V, et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am J Cardiol. 2012;109:581-586.
165. Gasparetto V, Fraccaro C, Tarantini G, et al. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2012 Mar 28 (ePub ahead of print).
166. Dewey TM, Brown DL, Herbert MA, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg. 2010;89:758-767; discussion 767.
167. Clavel MA, Webb JG, Rodés-Cabau J, et al. Comparison between trans-catheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122:1928-1936.
168. Unbehaun A, Pasic M, Buz S, et al. Transapical aortic valve implantation in patients with severely depressed left ventricular function. J Thorac Cardio-vasc Surg. 2012;143:1356-1363.
169. Fraccaro C, Al-Lamee R, Tarantini G, et al. Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. Circ Cardiovasc Interv. 2012;5:253-260.
170. van der Boon RM, Nuis RJ, Van Mieghem NM, et al. Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv. 2012;79:702-710.
171. Ewe SH, Ajmone Marsan N, Pepi M, et al. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following trans-catheter aortic valve implantation for severe aortic stenosis. Am Heart J. 2010;160:1113-1120.
172. Kukucka M, Pasic M, Dreysse S, et al. Patient-prosthesis mismatch after transapical aortic valve implantation: Incidence and impact on survival. J Thorac Cardiovasc Surg. 2012 Feb 11 (Epub ahead of print).
173. Tzikas A, Piazza N, Geleijnse ML, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the medtronic CoreValve system in patients with aortic stenosis. Am J Cardiol. 2010;106:255-260.
174. Ewe SH, Muratori M, Delgado V, et al. Hemodynamic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;58:1910-1918.
175. Kalavrouziotis D, Rodés-Cabau J, Bagur R, et al. Transcatheter aortic valve implantation in patients with severe aortic stenosis and small aortic annulus. J Am Coll Cardiol. 2011;58:1016-1024.
176. Lauten A, Zahn R, Horack M, et al.; German Transcatheter Aortic Valve Interventions Registry Investigators. Transcatheter aortic valve implantation in patients with low-fow, low-gradient aortic stenosis. JACC Cardiovasc Interv. 2012;5:552-559.
177. Reynolds MR, Magnuson EA, Lei Y, et al.; Placement of Aortic Transcath-eter Valves (PARTNER) Investigators. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124:1964-1972.
178. Reynolds MR, Magnuson EA, Wang K, et al.; PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol. 2012;60:548-558.
179. Fairbairn TA, Meads DM, Mather AN, et al. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J Am Coll Cardiol. 2012;59:1672-1680.
180. Amonn K, Stortecky S, Brinks H, et al. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Eur J Cardiothorac Surg. 2013;43:34-42.
181. Reynolds MR, Magnuson EA, Wang K, et al.; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125:1102-1109.
182. Reynolds MR, Magnuson EA, Lei Y, et al.; PARTNER Investigators. Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) Trial (Cohort A). J Am Coll Cardiol. 2012;60:2683-2692.
183. Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. J Thorac Cardiovasc Surg. 2012 Jul 11 (Epub ahead of print).
184. Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ. 2012;345:e4710.
185. Willson AB, Webb JG, Gurvitch R, et al. Structural integrity of balloon-expandable stents after transcatheter aortic valve replacement: assessment by multidetector computed tomography. JACC Cardiovasc Interv. 2012;5:525-532.
186. Nietlispach F, Webb JG, Ye J, et al. Pathology of transcatheter valve therapy. JACC Cardiovasc Interv. 2012;5:582-590.
187. Humphries KH, Toggweiler S, Rodés-Cabau J, et al. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2012;60:882-886.
188. Nuis RJ, Rodés-Cabau J, Sinning JM, et al. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Car-diovasc Interv. 2012;5:680-688.
189. Chiam PT, Chao VT, Tan SY, et al. Percutaneous transcatheter heart valve implantation in a bicuspid aortic valve. JACC Cardiovasc Interv. 2010;3:559-561.
190. Ferrari E, Locca D, Sulzer C, et al. Successful transapical aortic valve implantation in a congenital bicuspid aortic valve. Ann Thorac Surg. 2010;90:630-632.
191. Kochman J, Huczek Z, Koltowski Ł, et al. Transcatheter implantation of an aortic valve prosthesis in a female patient with severe bicuspid aortic stenosis. Eur Heart J. 2012;33:112.
192. Wijesinghe N, Ye J, Rodés-Cabau J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2010;3:1122-1125.
193. Himbert D, Pontnau F, Messika-Zeitoun D, et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol. 2012;110:877-883.
194. Chandola R, Cusimano R, Osten M, et al. Postcardiac transplant transcath-eter core valve implantation for aortic insuffciency secondary to Impella device placement. Ann Thorac Surg. 2012;93:e155-e157.
195. Dumonteil N, Marcheix B, Lairez O, et al. TAVI for severe, non-calcifed aortic regurgitation and narrow aortic root: Description from a case report of a new approach to potentially avoid coronary artery obstruction. Catheter Cardiovasc Interv. 2012 Jun 28 (Epub ahead of print).
196. Bleiziffer S. Successful treatment of pure aortic insuffciency with transapi-cal implantation of the Jena valve. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
197. Leon MB. Overview of large hole transfemoral and transapical access and closure devices. Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
198. Mack MJ. Novel transapical access and closure devices Transcatheter Valve Therapies Annual Symposium 2012. An Advanced Scientifc and Clinical Workshop with LAA Occlusion Therapies. Seattle, WA; 2012.
199. Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after trans-catheter aortic valve implantation: insights on prognostic factors and valve durability from the canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864-1875.
200. Webb J, Rodés-Cabau J, Fremes S, et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol. 2012;28:520-528.
201. Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation. 2010;122:1319-1327.
202. D'Errigo P, Barbanti M, Ranucci M, et al, on behalf of the OBSERVANT Research Group. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: Results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol. 2012 May 25 (Epub ahead of print).
203. Willson AB, Rodès-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: frst-in-human experience. J Am Coll Cardiol. 2012;60:581-586.
204. Meredith IT. The Lotus™ valve and the REPRISE clinical trial program. Transcatheter Cardiovascular Therapeutics (TCT) 25th Annual Symposium. San Francisco; 2011.
205. Treede H, Mohr FW, Baldus S, et al. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg. 2012;41:e131-e138.
206. Kempfert J, Treede H, Rastan AJ, et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52-57.
207. Treede H, Tübler T, Reichenspurner H, et al. Six-month results of a repo-sitionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J Thorac Cardiovasc Surg. 2010;140:897-903.
208. Sündermann SH, Grünenfelder J, Corti R, et al. Feasibility of the Engager™ aortic transcatheter valve system using a fexible over-the-wire design. Eur J Cardiothorac Surg. 2012;42:e48-e52.